Novel Biomarkers Help Decode Metastatic Breast Cancer
New research has found a connection between aggressive breast cancer cells and the dual CXCR4-CCR7 cell surface protein complexes.
Read MorePosted by Andy Lundin | Feb 4, 2022 | Breast |
New research has found a connection between aggressive breast cancer cells and the dual CXCR4-CCR7 cell surface protein complexes.
Read MorePosted by Andy Lundin | Feb 1, 2022 | Cancer, Company News |
Bio-Rad Laboratories introduced four inhibitory antibodies that are highly specific to pertuzumab (Perjeta).
Read MorePosted by Andy Lundin | Feb 1, 2022 | Molecular Diagnostics |
Researchers published a study on the design and application of nanoparticles as efficient delivery vehicles for biopharmaceutics.
Read MorePosted by Andy Lundin | Jan 28, 2022 | Covid 19 |
The severity of COVID-19 pneumonia can be difficult to assess in people from different ethnic groups, due to inaccurate readings from pulse oximeters.
Read MorePosted by Andy Lundin | Jan 27, 2022 | Diagnostic Technologies, Respiratory Disease |
LightDeck Diagnostics received a $2 million contract for the development of a rapid, quantitative, multiplexed test for inflammatory markers.
Read More